Antje-Christine Walz
Research Subjects
Research Interests
Antje-Christine Walz has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
Nicolas Frances
29 shared publications- Arthur J. Van De Vyver
Biomedical Research Novartis Basel Switzerland
21 shared publications Sylvia Herter
20 shared publicationsThorsten Lehr
20 shared publicationsTina Weinzierl
20 shared publicationsFlorian Limani
19 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Combining Nonclinical Experiments with Translational PKPD Modeling to Differentiate Erlotinib and Gefitinib
Shows the goodness of fit plots when fitting a 1-compartmental model to the long term plasma PK data.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Combining Nonclinical Experiments with Translational PKPD Modeling to Differentiate Erlotinib and Gefitinib
Shows the goodness of fit plots when fitting a 1-compartmental model to the long term plasma PK data.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Combining Nonclinical Experiments with Translational PKPD Modeling to Differentiate Erlotinib and Gefitinib
Displays the goodness of fit plots when fitting the PKPD model to tumor growth inhibition data in the cell line derived A431 xenografts.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Combining Nonclinical Experiments with Translational PKPD Modeling to Differentiate Erlotinib and Gefitinib
Displays the goodness of fit plots when fitting the PKPD model to tumor growth inhibition data in the cell line derived A431 xenografts.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S5 from Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling
Predicted versus observed values plots
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling
Predicted versus observed values plots
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling
Prediction distribution plots of MKN45 cell line
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling
Prediction distribution plots of MKN45 cell line